Latest Knott David M Jr Stock Portfolio
Knott David M Jr Performance:
2024 Q3: 19.44%YTD: 22.36%2023: 11.85%
Performance for 2024 Q3 is 19.44%, and YTD is 22.36%, and 2023 is 11.85%.
About Knott David M Jr and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Knott David M Jr reported an equity portfolio of $284.6 Millions as of 30 Sep, 2024.
The top stock holdings of Knott David M Jr are , , GOOG. The fund has invested 27.1% of it's portfolio in CALUMET SPECIALTY PRODUCTS PARTNERS, LP and 9.9% of portfolio in APOLLO GLOBAL MANAGEMENT, INC.
The fund managers got completely rid off CALUMET SPECIALTY PRODUCTS PARTNERS, LP (CLMT), LIGAND PHARMACEUTICALS INCORPORATED (LGND) and LUCKIN COFFEE, INC (LKNCY) stocks. They significantly reduced their stock positions in DOW INC. (DOW), COCA-COLA CO. (KO) and FS BANCORP, INC. (FSBW). Knott David M Jr opened new stock positions in CALUMET SPECIALTY PRODUCTS PARTNERS, LP, BIOMARIN PHARMACEUTICALS INC. (BMRN) and LEXICON PHARMACEUTICALS INC. (LXRX). The fund showed a lot of confidence in some stocks as they added substantially to KURA ONCOLOGY INC. (KURA), JANUS HENDERSON AAA CLO ETF (JAAA) and MEREO BIOPHARM GROUP PLC (MREO).
The top stock holdings of Knott David M Jr are , , GOOG. The fund has invested 27.1% of it's portfolio in CALUMET SPECIALTY PRODUCTS PARTNERS, LP and 9.9% of portfolio in APOLLO GLOBAL MANAGEMENT, INC.
The fund managers got completely rid off CALUMET SPECIALTY PRODUCTS PARTNERS, LP (CLMT), LIGAND PHARMACEUTICALS INCORPORATED (LGND) and LUCKIN COFFEE, INC (LKNCY) stocks. They significantly reduced their stock positions in DOW INC. (DOW), COCA-COLA CO. (KO) and FS BANCORP, INC. (FSBW). Knott David M Jr opened new stock positions in CALUMET SPECIALTY PRODUCTS PARTNERS, LP, BIOMARIN PHARMACEUTICALS INC. (BMRN) and LEXICON PHARMACEUTICALS INC. (LXRX). The fund showed a lot of confidence in some stocks as they added substantially to KURA ONCOLOGY INC. (KURA), JANUS HENDERSON AAA CLO ETF (JAAA) and MEREO BIOPHARM GROUP PLC (MREO).
Knott David M Jr Annual Return Estimates Vs S&P 500
Our best estimate is that Knott David M Jr made a return of 19.44% in the last quarter. In trailing 12 months, it's portfolio return was 29.89%.
New Buys
| Ticker | $ Bought |
|---|---|
| calumet specialty products partners, lp | 77,072,000 |
| biomarin pharmaceuticals inc. | 2,390,000 |
| lexicon pharmaceuticals inc. | 785,000 |
| zimvie inc. | 567,000 |
| atyr pharma, inc. | 189,000 |
| revance therapeutics inc. | 163,000 |
| linde plc | 33,000 |
| general electric company | 28,000 |
New stocks bought by Knott David M Jr
Additions
| Ticker | % Inc. |
|---|---|
| kura oncology inc. | 90.00 |
| janus henderson aaa clo etf | 58.86 |
| mereo biopharm group plc | 40.25 |
| xeris biopharma holdings, inc. | 21.95 |
| biocryst pharmaceuticals inc. | 21.54 |
| syndax pharmaceutical, inc. | 17.64 |
| omniab, inc. | 2.68 |
| immunovant inc. | 0.55 |
Additions to existing portfolio by Knott David M Jr
Reductions
| Ticker | % Reduced |
|---|---|
| dow inc. | -89.17 |
| coca-cola co. | -73.68 |
| fs bancorp, inc. | -66.67 |
| international game technology plc | -66.67 |
| viking therapeutics, inc. | -48.66 |
| evolus, inc. | -47.03 |
| ironwood pharmaceuticalss, inc. | -44.05 |
| leap therapeutics, inc. | -42.87 |
Knott David M Jr reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| calumet specialty products partners, lp | -69,416,000 |
| luckin coffee, inc | -2,110,000 |
| ligand pharmaceuticals incorporated | -7,162,000 |
| janus henderson aaa clo etf | -1,599,000 |
| bridgebio pharma, inc. | -532,000 |
| ovid therapeutics inc. | -15,000 |
| conagra brands, inc. | -284,000 |
| f.n.b. corporation | -122,000 |
Knott David M Jr got rid off the above stocks
Sector Distribution
Knott David M Jr has about 50.6% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 50.6 |
| Healthcare | 27.8 |
| Financial Services | 8.4 |
| Communication Services | 6.9 |
| Technology | 3.4 |
Market Cap. Distribution
Knott David M Jr has about 20.5% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 51.1 |
| SMALL-CAP | 15.7 |
| MEGA-CAP | 14.8 |
| MID-CAP | 12.3 |
| LARGE-CAP | 5.7 |
Stocks belong to which Index?
About 38.2% of the stocks held by Knott David M Jr either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 61.9 |
| S&P 500 | 19.7 |
| RUSSELL 2000 | 18.5 |
Knott David M Jr Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Knott David M Jr
Knott David M Jr has 92 stocks in it's portfolio. About 68% of the portfolio is in top 10 stocks. GOOG proved to be the most loss making stock for the portfolio. AB was the most profitable stock for Knott David M Jr last quarter.
Last Reported on: 13 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AAPL | apple inc. | 2.04 | 2,494 | 5,809,000 | unchanged | 0.00 | ||
| AB | alliancebernstein holding l.p. | 5.88 | 48,000 | 16,747,000 | reduced | -2.04 | ||
| ABBV | abbvie inc. | 3.50 | 5,037 | 9,947,000 | unchanged | 0.00 | ||
| ADBE | adobe | 0.06 | 35.00 | 181,000 | unchanged | 0.00 | ||
| AMZN | amazon.com inc. | 0.20 | 300 | 559,000 | unchanged | 0.00 | ||
| ARCH | arc resources ltd. | 0.07 | 1,110 | 187,000 | reduced | -9.68 | ||
| ARDX | ardelyx, inc. | 1.65 | 682,867 | 4,705,000 | reduced | -11.64 | ||
| AVDL | avadel pharmaceuticals plc | 1.53 | 332,000 | 4,354,000 | reduced | -0.3 | ||
| AVGO | broadcom, inc. | 0.04 | 710 | 122,000 | unchanged | 0.00 | ||
| BBIO | bridgebio pharma, inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BCRX | biocryst pharmaceuticals inc. | 1.02 | 382,000 | 2,903,000 | added | 21.54 | ||
| BIL | spdr s&p biotech etf | 0.35 | 10,000 | 988,000 | reduced | -28.57 | ||
| BMRN | biomarin pharmaceuticals inc. | 0.84 | 34,000 | 2,390,000 | new | |||
| BX | blackstone group lp | 0.01 | 210 | 32,000 | unchanged | 0.00 | ||
| CAG | conagra brands, inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CC | the chemours company | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CLMT | calumet specialty products partners, lp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CMG | chipotle mexican grill, inc. | 0.01 | 500 | 29,000 | unchanged | 0.00 | ||
| CPRX | catalyst pharmaceuticals, inc. | 1.48 | 212,000 | 4,215,000 | unchanged | 0.00 | ||
| CRM | salesforce, inc. | 0.01 | 77.00 | 21,000 | unchanged | 0.00 | ||